Bruce Larson, PhD
Research Professor
Boston University School of Public Health
Global Health

PhD, University of Wisconsin Madison
MA, University of Wisconsin Madison
BA, University of Wisconsin Madison

Dr. Larson is an applied economist with the Department of Global Health. Dr. Larson has conducted research activities in about 25 countries over the past 30 years, mainly in Africa, the former Soviet Union and the US. Before joining Boston University, Larson was an Associate Professor in the Department of Agricultural and Resource Economics at the University of Connecticut, a Research Associate with the Harvard Institute for International Development, a Research Fellow with Winrock International, and an Agricultural Economist with the U.S. Department of Agriculture. As part of these activities, he was based in Tallinn, Riga, and Moscow during 1994-1997 and Nairobi during 2005-2006.

Since joining Boston University, his research has focused on economic evaluations of public health programs and interventions in clinical and community settings with experimental and quasi-experimental designs. Most of this evaluation work has been based on primary data collected in collaboration with colleagues and institutions in the country of focus (e.g., the Kenya Medical Research Institute/ Walter Reed Project, the Health Economics and Epidemiology Office of the University of Witwatersrand, and the Zambia Centre for Applied Health Research and Development). His evaluation research has addressed a range of topics, such as the impacts of HIV treatment on labor productivity, costs and usefulness of point-of-care technologies (CD4 tests, rapid syphilis tests, rapid malaria tests), costs of HIV care and treatment, and improving delivery of prevention of mother-to-child transmission).

An Enhanced Package of Care to Reduce Mortality in Persons with Advanced HIV Disease
08/23/2021 - 07/31/2026 (Subcontract PI)
Regents of the University of Minnesota NIH NIAID

Multi-Sectoral Agricultural Intervention to Improve Nutrition, Health, and Developmental Outcomes of HIV-infected and Affected Children in Western Kenya
08/01/2018 - 07/31/2022 (Subcontract PI)
University of Connecticut NIH NIMH

Boston University’s Contributions to the Enhanced Mentor Mother Program (EMMA) Study for USG FY2021-22.
09/30/2020 - 09/29/2021 (Subcontract PI)
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. DOD ArmyMedResMatCmd

Crypotoccal Meningitis Screening in South Africa
05/01/2015 - 06/30/2021 (Subcontract PI)
CDC Foundation Pfizer, Inc

Boston Universitys Contributions to the Enhanced Mentor Mother Program (EMMA) Study for USG FY2019
09/30/2018 - 09/29/2019 (Subcontract PI)
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. DOD ArmyMedResMatCmd

Public Health Evaluation Study
02/01/2011 - 09/30/2018 (Subcontract PI)
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. DOD Army Med Resrch

Malaria Control and Elimination Partnership in Africa (MACEPAll): Costing Studies
04/01/2014 - 09/30/2016 (Subcontract PI)
PATH Bill & Melinda Gates

Uganda Circumcision Project: Cost and outcome comparisons of safe male circumcision service delivery models in rural Uganda
01/01/2012 - 09/30/2013 (Subcontract PI)
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. DOD Army Med Resrch

Public Health Evaluation Study
02/01/2011 - 09/14/2012 (PI)
Henry M. Jackson Foundation USAID


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Larson BA, Tsikhutsu I, Bii M, Halim N, Agaba P, Sugut W, Muli J, Sawe F. The effects of revised peer-counselor support on the PMTCT cascade of care: results from a cluster-randomized trial in Kenya (the EMMA study). BMC Infect Dis. 2023 Apr 25; 23(1):257.View Related Profiles. PMID: 37098468; PMCID: PMC10127503; DOI: 10.1186/s12879-023-08246-4;
  2. Rajasingham R, Nalintya E, Israelski DM, Meya DB, Larson BA, Boulware DR. Cost-effectiveness of single-dose AmBisome pre-emptive treatment for the prevention of cryptococcal meningitis in African low and middle-income countries. Med Mycol. 2022 Feb 01; 60(2). PMID: 35026017; PMCID: PMC9756002; DOI: 10.1093/mmy/myab078;
  3. Long LC, Rosen S, Nichols B, Larson BA, Ndlovu N, Meyer-Rath G. Getting resources to those who need them: the evidence we need to budget for underserved populations in sub-Saharan Africa. J Int AIDS Soc. 2021 07; 24 Suppl 3:e25707.View Related Profiles. PMID: 34189873; PMCID: PMC8242975; DOI: 10.1002/jia2.25707;
  4. Larson B, Shroufi A, Muthoga C, Oladele R, Rajasingham R, Jordan A, Jarvis JN, Chiller TM, Govender NP. Induction-phase treatment costs for cryptococcal meningitis in high HIV-burden African countries: New opportunities with lower costs. Wellcome Open Res. 2021; 6:140. PMID: 35706922; PMCID: PMC9184925; DOI: 10.12688/wellcomeopenres.16776.2;
  5. Larson BA, Pascoe SJS, Huber A, Long LC, Murphy J, Miot J, Fraser-Hurt N, Fox MP, Rosen S. Fast-track treatment initiation counselling in South Africa: A cost-outcomes analysis. PLoS One. 2021; 16(3):e0248551.View Related Profiles. PMID: 33735206; PMCID: PMC7971492; DOI: 10.1371/journal.pone.0248551;
  6. Tenforde MW, Muthoga C, Ponatshego P, Ngidi J, Mine M, Greene G, Jordan A, Chiller T, Larson BA, Jarvis JN. Cost-effectiveness of cryptococcal antigen screening at CD4 counts of 101-200 cells/µL in Botswana. Wellcome Open Res. 2021; 6:55. PMID: 35087954; PMCID: PMC8767426; DOI: 10.12688/wellcomeopenres.16624.2;
  7. Radford, Arden Geddes, Jeffrey A. Gallagher, Kevin Larson, Bruce A. Open-source methods for estimating health risks of fine particulate matter from coal-fired power plants: A demonstration from Karachi, Pakistan. Environmental Impact Assessment Review. 2021; 91:106638. View Publication
  8. Brennan A, Maskew M, Larson BA, Tsikhutsu I, Bii M, Vezi L, Fox M, Venter WDF, Ehrenkranz PD, Rosen S. Prevalence of TB symptoms, diagnosis and treatment among people living with HIV (PLHIV) not on ART presenting at outpatient clinics in South Africa and Kenya: baseline results from a clinical trial. BMJ Open. 2020 09 06; 10(9):e035794.View Related Profiles. PMID: 32895266; PMCID: PMC7476481; DOI: 10.1136/bmjopen-2019-035794;
  9. Yukich JO, Scott C, Silumbe K, Larson BA, Bennett A, Finn TP, Hamainza B, Conner RO, Porter TR, Keating J, Steketee RW, Eisele TP, Miller JM. Cost-Effectiveness of Focal Mass Drug Administration and Mass Drug Administration with Dihydroartemisinin-Piperaquine for Malaria Prevention in Southern Province, Zambia: Results of a Community-Randomized Controlled Trial. Am J Trop Med Hyg. 2020 08; 103(2_Suppl):46-53. PMID: 32618249; PMCID: PMC7416981; DOI: 10.4269/ajtmh.19-0661;
  10. Larson BA, Pascoe SJ, Huber A, Long LC, Murphy J, Miot J, Fox MP, Fraser-Hurt N, Rosen S. Will differentiated care for stable HIV patients reduce healthcare systems costs? J Int AIDS Soc. 2020 07; 23(7):e25541.View Related Profiles. PMID: 32686911; PMCID: PMC7370539; DOI: 10.1002/jia2.25541;
Showing 10 of 116 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 113 publications over 33 distinct years, with a maximum of 9 publications in 2013


In addition to these self-described keywords below, a list of MeSH based concepts is available here.

cost-effectiveness analysis
costing analyses
economic evaluation
health economics
sub-Saharan Africa, the former Soviet Union
Contact for Mentoring:

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map

Larson's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department